Method

Nanopore sequencing identifies high-frequency somatic structural variations in laryngeal squamous cell carcinoma genomes

    • 1Laboratory of Omics Technology and Bioinformatics, Frontiers Science Center for Disease-Related Molecular Network, State Key Laboratory of Biotherapy, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;
    • 2Department of Otolaryngology–Head and Neck Surgery, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China;
    • 3Deep Underground Space Medical Center, West China Hospital, Sichuan University, Chengdu, Chengdu, Sichuan 610041, China
    • 4 These authors contributed equally to this work.
Published April 8, 2026. https://doi.org/10.1101/gr.281046.125
Download PDF Cite Article Permissions Share
cover of Genome Research Vol 36 Issue 10
Current Issue:

Abstract

Laryngeal squamous cell carcinoma (LSCC) is an aggressive cancer associated with poor quality of life. Understanding the somatic mutations in its genome is crucial for elucidating its occurrence and progression. Although somatic structural variations (SVs) have been documented in LSCC, conventional short-read sequencing lacks the sensitivity to effectively detect high-frequency SVs, variants that play a crucial role in tumorigenesis, shared across multiple samples. Here, we present SomaGauss-SV, a somatic SV detection workflow leveraging nanopore long-read sequencing data. Benchmarking against five paired tumor cell line data sets shows SomaGauss-SV consistently achieves a balanced high precision and recall. SomaGauss-SV applied to 15 paired LSCC tumor-blood samples uncovers a comprehensive SV landscape and reveals a significant positive correlation between somatic deletion burden and smoking intensity. Furthermore, a high-frequency somatic simple repeat expansion is identified in 28/39 (71.79%) of LSCC patients, which upregulates the expression of genes TP53BP2 and FBXO28 through spatial proximity. These findings underscore the potential of long-read sequencing and SomaGauss-SV for uncovering recurrent somatic SVs in LSCC, providing valuable resources for biomarker discovery.

Loading
Loading
Loading
Back to top